Background {#Sec1}
==========

Acute cholecystitis (AC) describes an acute gallbladder inflammation and is a common cause for a visit to the emergency department \[[@CR1]\]. Although gallbladder stones are present in the vast majority of cases (calculous cholecystitis), gallbladder inflammation is possible in the absence of stones (acalculous cholecystitis). Patients usually present with pain to the right upper quadrant with fever and chills. AC is easily diagnosed using the parameters outlined in the Tokyo (TG13) guidelines. These guidelines employ information from history, physical examination, blood chemistry, and ultrasound sonography to diagnose AC. Besides providing diagnostic criteria, the TG13 guidelines enable a classification of AC in three severity grades; mild cholecystitis (grade I), moderate cholecystitis (grade II), and severe cholecystitis with organ failure (grade III) \[[@CR2], [@CR3]\].

Cholecystectomy, that is the surgical removal of the gallbladder, is generally accepted as the standard treatment for "fit for surgery" patients with AC \[[@CR4]--[@CR8]\]. Nowadays, the minimal invasive laparoscopic technique is the standard procedure for the management of benign gallbladder pathologies including AC. However, the management of critically ill patients with AC remains controversial. Although surgery has been employed in such patients, increased risk of perioperative morbidity and mortality due to reduced physiologic reserve is of concern. Thus, percutaneous cholecystostomy (PC), i.e., draining the inflamed gallbladder under local anesthesia, has been proposed and employed in the management of such patients, especially after failure of medical therapy \[[@CR9]--[@CR13]\].

Currently, many research groups have published their experience with PC either as a bridge to surgery or as a definitive intervention in critically ill patients with AC \[[@CR11], [@CR14], [@CR15]\]. Although the results presented by some of these series appear acceptable, the small size of the study population, the retrospective study design, and possible selection bias limit their clinical value. More so, the clinical value of PC in the management of critically ill patients with cholecystitis could not be established in a systematic review by Winbladh et al. \[[@CR16]\] in 2007. Similarly, a Cochrane review by Gurusamy et al. \[[@CR17]\] in 2013 failed to identify the clinical significance of PC in the management of AC. This review included just 156 patients from two randomized studies and was inconclusive with regard to the clinical benefit of PC in the management of critically ill patients with AC.

In a recently published 10-year retrospective analysis, Abi-Haidar et al. \[[@CR18]\] reported longer intensive care unit stay and hospital stay in patients managed with PC. In this series, PC was associated with higher morbidity and re-admission rates compared to CC. A similar trend was reported in a large retrospective series by Anderson and colleagues \[[@CR19]\]. The rate of mortality for PC in their series of 43.341 patients was 61.7 %. The authors concluded, "PC may not benefit the sickest patients in whom cholecystectomy may never be considered".

The heterogeneity of clinical presentation and comorbidities of patients with AC makes it extremely difficult to standardize management. Therefore, the clinical decision-making may not always be clear. This is especially true for elderly and critically ill patients with reduced physiologic reserve. However, modern surgical techniques as well as advances in anesthesiology and intensive care medicine could permit primary gallbladder surgery in critically ill patients.

This systematic review will compare the outcomes of critically ill patients managed with PC to those of similar patients managed with CC with the primary aim of establishing the clinical role of PC in the management of critically ill patients with AC.

Objectives {#Sec2}
----------

This review will provide an overview of published data on PC and CC in the management of critically ill patients with AC. The clinical benefit of PC in the management of this subgroup of patients will be investigated by comparing the outcomes of both interventions.

Methods/design {#Sec3}
==============

Study type {#Sec4}
----------

We will consider all studies comparing CC and PC for the definite management of critically ill patients with AC irrespective of the presence or absence of gallbladder stones and the use of antibiotics or supportive care. Thus, studies with PC prior to CC will not be included. Since no randomized controlled trials (RCTs) exist on this topic, data for this systematic review will be acquired mainly from retrospective studies; if the question cannot be answered with certainty, this will inform the decision on whether a randomized controlled trial is needed and the number of patients required. Only studies published in English language will be included. Relevant studies in languages other than English will be considered, if an English translation is available. In such cases, a translation will be requested from the corresponding authors. Only articles published after the comprehensive availability of modern surgical techniques (minimal invasive surgery) as well as advances in anesthesiology and intensive care medicine will be included for analysis. Therefore, the search will be limited to articles published after January 1, 2000. Furthermore, all series with less than 20 participants as well as case reports will be excluded. Since a high degree of heterogeneity is expected, there will be no limits in the length of follow-up.

Participants {#Sec5}
------------

All patients included in eligible studies will be considered for analysis without restriction.

Interventions {#Sec6}
-------------

Cholecystectomy and PC constitute the interventions to be compared.Cholecystectomy will be defined as the surgical removal of the gallbladder independent of the means of access, i.e., laparoscopic or open.Percutaneous cholecystostomy refers to the placement of a drain or a tube with the aim of draining the gallbladder content. This is usually performed under local anesthesia and image guidance via ultrasound or computed tomography.

Primary outcomes {#Sec7}
----------------

The primary outcomes will include in-hospital mortality, 30-day mortality, and the rate of complications. Only procedure-related complications will be analyzed since medical complications are not always procedure related.

Secondary outcomes {#Sec8}
------------------

Re-intervention: any form of surgical, endoscopic or radiologic intervention following PC or CCLength of intensive care unit (ICU) stayLength of hospital stayRe-admission for biliary complaintsCost of treatment

Search for eligible studies {#Sec9}
---------------------------

Systematic searches will be conducted across relevant health databases including the Cochrane Library, Cumulative Index of Nursing and Allied Health Literature (CINAHL), MEDLINE, Embase, and Scopus using the following keywords: (acute cholecystitis OR severe cholecystitis OR cholecystitis) AND (cholecystectomy OR laparoscopic cholecystectomy OR open cholecystectomy) AND (Cholecystostomy OR percutaneous cholecystectomy OR gallbladder drain OR gallbladder tube OR transhepatic gallbladder drain OR transhepatic gallbladder tube OR cholecystostomy tube). The reference lists of eligible articles will be hand searched. Articles published after January 1 2000 will be identified using the key terms "acute cholecystitis, cholecystectomy, and percutaneous cholecystostomy."

Study selection {#Sec10}
---------------

The title and abstract of each article will be screened and assessed against predetermined inclusion criteria by two independent investigators MP and SW. Each investigator must give a reason for rejecting any article. Unclear cases will be discussed with PA. A detailed full-paper assessment will be performed for each study deemed eligible for inclusion. This will be done independently and unblinded by MP, SW, and PA. Disagreements will be discussed with PA and if necessary, a fourth investigator, HZ, will be consulted. All consensuses reached must be in accordance with the protocol. The corresponding authors of eligible articles will be contacted for clarification (e.g., missing data, etc.) where necessary.

Data extraction {#Sec11}
---------------

A data extraction sheet designed for this systematic review by SK and PA will be used for data extraction. MP and SW will independently extract data from the included studies. PA will cross-check the extracted data. Disagreements will be resolved in all cases via discussion. If no agreement is reached, HZ will be consulted for consensus.

The following information will be extracted:Publication language, year, and country of originBaseline features: age, sex, American Society of Anesthesiologists (ASA) score, and body mass index (BMI)Size of study populationStudy designInclusion criteriaType of intervention: PC and CCAllocation criteria for the respective interventionsLength of ICU stay in daysLength of hospital stay in daysDuration of follow-upMorbidity and mortality ratesRe-intervention: type and reasons of re-interventionRe-admission for biliary complaintsCost of treatment

Assessment of risk of bias {#Sec12}
--------------------------

SK and MP will assess risk of bias of all the studies included. As per the instructions outlined in the Cochrane Handbook for systematic reviews of interventions, the Newcastle-Ottawa scale will be used to assess quality of non-randomized studies. Two previous systematic reviews \[[@CR16], [@CR17]\] (search to 2012) identified no randomized controlled trials directly comparing PC and CC; if an adequate number of trials are identified in our search, the analysis protocol proposed by the Cochrane Systematic Review \[[@CR17]\] will be followed. If necessary, the corresponding authors of included articles will be contacted for further information.

Measurement of treatment effect {#Sec13}
-------------------------------

Central tendencies will be reported in terms of means and standard deviations where necessary. If not reported, the standard deviation will be calculated from the standard error of the mean. The corresponding authors will be contacted whenever such data are missing. Risk ratios will be calculated where possible. All calculations will be performed with a 95 % confidence interval. Furthermore, the Fisher's exact test will be used for the calculation of significance, which will be set at *p* \< 0.05. Adjusted effect estimates will be analyzed in preference to the unadjusted estimates, using inverse-variance weighted average. Pooled estimates will only be presented after consideration of both clinical and methodological heterogeneity of included studies. If there is significant clinical or methodological heterogeneity, we will consider pooling only homogeneous studies. If this is thought to introduce too much bias, we will abandon the meta-analysis altogether.

Unit of analysis {#Sec14}
----------------

The unit of study will be critically ill patients with AC, both calculous and acalculous cholecystitis.

Dealing with missing data {#Sec15}
-------------------------

The responsible author will be contacted whenever possible to request for missing data. Assumption methods used to cope with missing data will be clearly outlined. If necessary, sensitivity analyses will be carried out to assess how sensitive the results will react to changes in assumption. These will be fully discussed in the review.

Assessment of heterogeneity {#Sec16}
---------------------------

The Chi square test with a *p* value of 0.05 will be used to explore heterogeneity while the quantity of heterogeneity will be assessed using *I*^2^ statistics. *I*^2^ will be interpreted according to the guidance for Cochrane reviews. It is expected that a random effects model will be used to build up the meta-analysis.

Assessment of reporting bias {#Sec17}
----------------------------

We plan to use visual inspection of the funnel plots to assess reporting bias if sufficient studies are available. We plan to use the linear regression approach described by Egger \[[@CR20]\] to determine the funnel plot asymmetry. Possible sources of any funnel plot asymmetry will be explored since there may be publication bias but no asymmetry.

Subgroup analysis {#Sec18}
-----------------

Subgroup analyses will be performed for the primary endpoints. These analyses will be stratified by groups of patients managed with CC vs. PC. We will also perform subgroup analyses stratified by gender, ASA score, age, and BMI if possible. In the event that stratified gender, ASA score, age, and BMI analyses are not possible, we will use meta-regression to perform analyses adjusted for the percentages of males/females, ASA scores, BMI (mean or median), and age (mean or median).

Sensitivity analysis {#Sec19}
--------------------

Sensitivity analysis will be performed to investigate the influence of changes in the methods or data used in the individual articles on the review. This will be done for suitable features during the review process.

Discussion {#Sec20}
==========

AC is a common diagnosis, and the management of critically ill patients can be challenging with high rates of morbidity and mortality. While surgery is generally offered to "fit for surgery" patients, the management of critically ill patients is unclear. Percutaneous cholecystostomy has been used in such patients after failure of medical treatment. However, this procedure has been shown to be associated with unacceptably high rates of complications and mortality.

This systematic review will give an overview of the existing data on the management of critically ill patients with AC. Directly comparing the outcomes of patients managed with cholecystectomy to those of similar patients managed with cholecystostomy may help facilitate the clinical decision-making.
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